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Abstract
Objectives: The aim of this narrative review was to collect all findings from literature
about oral signs and symptoms of COVID-19, in order to draw a picture of oral
involvement of this challenging viral infection, to help oral professionals in a better
triage and early diagnosis.
Material and methods: The search for international literature was made including
articles written in English and reporting about oral manifestations in patients with a
diagnosis of COVID-19. The publication time was limited to 2019 and 2020, up to
May 20, 2020. A narrative review was performed.
Results: Twenty-three articles were included in this review. Three different oral man-
ifestations were found: taste alteration, oral blister and ulcers, and oral lesions associ-
ated with Kawasaki-like diseases (erythema, bleeding of lips, “strawberry tongue”).
The higher expression of Angiotensin-converting enzyme 2 in the oral cavity and in
endothelial cells might be responsible for oral manifestation and the major report of
signs and symptoms in the occidental countries.
Conclusions: Detecting oral signs and symptoms of COVID-19 could be useful to
perform a better preliminary triage in dental setting, and in recognizing possible early
manifestations of the disease. However, considering the outbreak of COVID-19 and
the consequent difficulty of undergoing oral examinations, the oral manifestations
might be misdiagnosed; then, we would encourage oral professionals to perform
other studies about this topic.
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1 | INTRODUCTION
The coronavirus disease 2019 (COVID-19), caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), started from
Wuhan, China, in December 2019. On January 30, 2020, the World
Health Organization (WHO) announced “a public health emergency of
international concern” (Sohrabi et al., 2020) and on March 11, declared
the pandemic condition.
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This disease had high virulence with the human-to-human trans-
mission, with an incubation period ranged from 2 to 14 days (Jiang
et al., 2020).
Several studies reported that novel Coronavirus 2019 uses
Angiotensin-converting enzyme 2 (ACE2) as its host receptor (Wan,
Shang, Graham, Baric, & Li, 2020; Zhang, Penninger, Li, Zhong, &
Slutsky, 2020), used for host cell entry and then, viral replication.
Lung appears to be the target organ and common clinical features
of this virus infection were fever, respiratory involvement, dry cough
and diarrhea (Jiang et al., 2020). However, the exponential diffusion
of the COVID-19 infection around the world showed some new clini-
cal signs of the disease (e.g., cutaneous [Tang et al., 2020], gastroin-
testinal [Lee, Huo, & Huang, 2020] manifestations). It was reported
that atypical manifestations could be in some cases the first and/or
the only manifestations of this disease (Daruich, Martin, & Bremond-
Gignac, 2020; Wang, Wang, Chen, Tao, & Zeng, 2020); therefore, in
this context, all specialists can contribute to early diagnosis, then to
control outbreaks, identifying early signs and symptoms of COVID-19
to speed-up self-isolation procedures.
Rapid detection of COVID-19 is crucial to control outbreaks: only
by means of an early identification of manifestations and consequent
early diagnosis, it is possible an effective and rapid isolation of cases
and the appropriate contact tracing.
Indeed, the literature reported that case isolation was more effec-
tive when the delay from symptom onset to isolation was short
(Hellewell et al., 2020).
The aim of this brief narrative review was to outline the oral
signs and symptoms observed in patients diagnosed with COVID-19
reported in the literature, in order and to better profile the role of oral
professionals and what they may have to know. Other studies and
reports about this topic are surely required.
2 | METHODS
Two of the authors (CG, NR) independently performed a literature
search on PUBMED and PMC. At the beginning, the following search
strategy was uploaded, combining free words and MESH terms: (oral
manifestation) AND (COVID19 OR Coronavirus Disease 2019 OR
SARS-CoV-2). Therewith, in this literature research, studies describing
cutaneous manifestation were included, because these are often
associated with oral manifestations, as described for some disease
(Capocasale et al., 2017; Zotti et al., 2020), and therefore reported by
dermatologists.
Considering the timing of the spread of the disease, the publica-
tion time was limited to 2019 and 2020, up to May 20, 2020. We
had included all types of studies regarding the oral manifestations
observed in patients diagnosed with COVID-19, only literature reviews
were excluded. Other exclusion criteria were: articles for which full
text was not available, articles were not in English or were grey
literature.
Duplicate articles were eliminated and the first evaluation was
performed reading only the title and abstract of the studies. Later, all
studies considered eligible were included for full-text evaluation and
only studies considered eligible by both authors were included in the
review.
From those retrieved during the search, additional references
were identified by a manual search among the cited references.
3 | RESULTS
From the first search resulted in 515 works, 508 resulted after check-
ing of duplicates. By searching in references resulted, 17 were
retrieved. Finally, according to inclusion and exclusion criteria, 23 were
included for the narrative review. The literature selection process was
reported in the diagram (Table 1).
Results were synthesized in Table 2: name of the first author and
year, country of the diagnosed cases, oral sign or symptom reported,
sample size, patients' age, gender and studies design were inserted. In
addition, crucial information found in these studies were also pres-
ented. Given that the studies were published between December
2019 and May 20, 2020, results were set in the table in alphabetical
order, by the surnames of the first authors, and divided considering
the oral signs or symptoms described.
In the sections below, oral manifestations observed were
described.
3.1 | Taste alteration
A pool of 5,399 patients diagnosed with COVID-19 resulted from
studies selected, from those 1,581 subjects (29.28%) reported taste
alteration as a symptom.
Taste alteration was found to be the most reported and thus
described oral manifestation during the COVID-19 with a range of
prevalence between 5.6% (Mao et al., 2020) and 92.64% (Bénézit
et al., 2020). Studies analyzed outlined a varied picture of taste
alterations, such as ageusia, hypogeusia and dysgeusia. Also, Jang
et al. (2020) brought to the attention of scientific community a case
of a 42-year-old male who reported both loss of taste and smell and
but also having a metallic taste. He was only this manifestation of the
disease, and he screened for COVID-19 only because he reported to
had proximity with a COVID-19 positive subject.
Paderno et al. (2020) reported that in 11% of cases patients men-
tioned the taste alteration as the first symptom of COVID-19 infec-
tion occurred, whereas other authors even described taste alteration
as the only one symptom detected of this infection (Hjelmesæth &
Skaare, 2020; Jang et al., 2020; Villalba et al., 2020).
A result was the identification of a statistically significant associa-
tion between taste alteration, female gender and early age (Bénézit
et al., 2020; Gelardi et al., 2020; Giacomelli et al., 2020; Jang et al.,
2020; Lechien et al., 2020); however, one study not reported a signifi-
cant association with early age (Yan et al., 2020).
Beltrán-Corbellini et al. (2020) compared a cohort of 79 patients
diagnosed with COVID-19 to a cohort of 40 patients suffering from
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seasonal flu (as control) with similar demographic characteristics. Loss
of smell and taste was found statistically significant in the cohort of
COVID-19 patients, 11 of them also reported dysgeusia and anosmia
as the first symptom occurred.
Roland et al. (2020) reported a high specificity (73%) of dysgeusia
and anosmia in diagnosing COVID-19 and (Bénézit et al., 2020)
found a 95% specificity of dysgeusia according to Wee et al. (2020)
(98.7%, 95% CI 97.6–99.4%), but lower sensitivity (22.7%, 95% CI
16.4–30.2%).
Some authors considered dysgeusia and anosmia, regardless
of the differences (Beltrán-Corbellini et al., 2020; Lee, Min, Lee, &
Kim, 2020; Roland et al., 2020; Vaira, Deiana, Fois, et al., 2020), fur-
thermore, in some works (Lechien et al., 2020), a positive association
between the two symptoms was reported (p < .001).
3.2 | Oral blister and ulcers
At the present, few studies cited oral lesions during COVID-19 infec-
tion; in detail, only one work by Martín Carreras-Presas et al. (2020)
reported three cases of diffuse oral pain, desquamative gingivitis,
ulcers and blisters. However, only one of these was actually diagnosed
with the COVID-19: the patient was a female of 65 years old, who had
blisters in her internal lip mucosa as well as desquamative gingivitis.
The authors recognized the case as Erythema Multiforme-like
eruption.
From literature analysis, oral manifestations were also reported
associated with other dermatological alteration; Jimenez-Cauhe et al.
(2020) mentioned three COVID-19 positive females, aged between
58 and 77 years old, with palatal macules and petechiae associated
with Erythema Multiforme-like eruption. This manifestation was found
to occur on average 19.5 days after the presumed infection. In addi-
tion, Hedou et al. (2020) reported 1 case of herpetic stomatitis of
100 intubated patients.
3.3 | Kawasaki-like disease
One of the issues of interest during the COVID outbreak was found
to be the potential association between Kawasaki disease (KD) and
the Coronavirus infection.
The KD can display changes of the lips and oral cavity, including
erythema, dryness, fissuring, peeling, cracking, bleeding of lips, “straw-
berry tongue.”
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Spain 28/79 48 M-31 F 61.6 Case control/self-reported
Bénézit et al., 2020 Taste
alteration






Italy 52/72 39 M-33 F 49.7 Case series/medical history
Giacomelli et al., 2020 Taste
alteration
Italy 17/59 40 M-19 F 60 Cross-sectional study/
self-reported
Hjelmesæth & Skaare, 2020 Taste
alteration
Norway 3/4 NR NR Case series/self-reported.
Family cases
Jang et al., 2020 Taste
alteration
Korea 1/1 M/42 42 Case report/self-reported
Lechien et al., 2020 Taste
alteration




Lee, Huo, & Huang, 2020 Taste
alteration
Korea 488/3.191 1.161 M-2.030 F 44 Retrospective study/
self-reported
Mao et al., 2020 Taste
alteration






USA 1/1 F 59 Case report/medical history-
self-reported
Paderno et al., 2020 Taste
alteration
Italy 284/508 285 M-223 F 55.15 Cross-sectional study/
self-reported
Roland, Gurrola, Loftus,
Cheung, & Chang, 2020
Taste
alteration
USA 96/145 40 M-105 F 39 Cross-sectional study/
self-reported survey
Vaira et al., 2020 Taste
alteration
Italy 62/320 NR NR Cross-sectional study/
medical history




Italy 39/72 27 M-45 F 49.2 Cross-sectional study/taste
test
Vaira et al., 2020 Taste
alteration
Italy 17/33 11 M-22 F 51.8 Cross-sectional study/
self-administrate taste test
Villalba et al., 2020 Taste
alteration
France 1/2 1 M-1 F 82.5 Case series/medical history
Wee et al., 2020 Taste
alteration















Spain 1/3 1 F 65 Case series/EM-like lesion
Hedou et al., 2020 Oral blister
and ulcers
France 1/103 32 M-71 F 47 Cross-sectional study/HSV in
intubated patient
Jimenez-Cauhe et al., 2020 Oral blister
and ulcers
Spain 3/4 4 F 66.65 Case series/EM-like lesion
Rivera-Figueroa, Santos,
Simpson, & Garg, 2020
Kawasaki-like
disease
USA 1/1 M 5 Case report/incomplete KD
Verdoni et al., 2020 Kawasaki-like
disease
Italy 5/10 7 M-3 F 7.5 Retrospective study/
4 patients with a classic
form and 1 with incomplete
had oral manifestation
Abbreviations: EM-like lesion, Erythema Multiforme-like eruption; F, female; HSV, Herpes simplex virus; KD, Kawasaki disease; M, male; NR, not reported.
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A deep investigation of this pathology could be useful for oral
professionals in order to disclose potential differential diagnoses or
perform early diagnosis. When KD occurs in association with COVID-
19, its clinical manifestations are worse when compared with clinical
features reported in the literature. Therefore, in these cases, it was
reported as Kawasaki-like disease (Verdoni et al., 2020).
An Italian observational study by Verdoni et al. (2020) showed
that, during the COVID-19 outbreak, KD had a monthly incidence at
least 30 times higher than the monthly incidence of the previous
5 years in the Bergamo district. The study reported 10 pediatric
patients affected by this condition, 5 of them showed the classic form
and 5 the incomplete form. Eighty percent of patients diagnosed
with classic form presented changes of the lips or oral cavity, or both
and one of them showed later cervical lymphadenopathy. Non-
exudative conjunctivitis associated with changes in the lips and oral
mucosa was highlighted in one of the patients affected by Kawasaki
incomplete form.
Furthermore, a case report from the United States described a
5-year-old patient, diagnosed with incomplete Kawasaki associated
with fever (up to 39.4C for 8 days), dry, cracked and erythematous
lips, non-exudative conjunctivitis and bilateral cervical lymphadenopa-
thy without skin rash (Rivera-Figueroa et al., 2020).
4 | DISCUSSION
A wide spectrum of signs and symptoms were reported in association
with novel COVID-19, however, few studies highlighted oral clinical
manifestations observed in patients diagnosed with this disease.
One of the most described oral symptoms was the taste alteration;
indeed, a recent review of literature noted the 43.93% (95% CI,
20.46–68.95%) prevalence of gustatory dysfunction (Tong, Wong,
Zhu, Fastenberg, & Tham, 2020). In this work, prevalence was reported
ranged between 5.6% (Mao et al., 2020) and 92.64% (Bénézit
et al., 2020), and in some case taste alteration was the first symptom
of COVID-19 (Gelardi et al., 2020; Hjelmesæth & Skaare, 2020; Melley
et al., 2020; Villalba et al., 2020; Vinayachandran & Balasubramanian,
2020); no less, a statistically significant association was found with
young age and female gender (Beltrán-Corbellini et al., 2020;
Giacomelli et al., 2020; Lechien et al., 2020; Lee, Huo, & Huang, 2020).
However, these results deserve to be more carefully evaluated
due to some critical issues, considering that this is a very subjective
symptom and it is difficult to diagnose. Primarily, it should be consid-
ered that several studies documented symptoms based on self-
reported and it could lead to an underestimation of them. Among all
studies selected in our review, only the work by Lechien et al. (2020)
assessed taste alteration using a validated questionnaire, the taste and
smell disorders component of the National Health and Nutrition
Examination Survey (NHANES). However, Vaira, Salzano, Deiana, and
De Riu (2020) tested these alterations by means of different solutions
(sweet, salted, acid and sour solutions) and they scored results. These
three studies were found to be similar in terms of incidence of taste
alteration, indicating values of 88.8, 73.6 and 51.5% respectively.
Other studies that assessed this symptom based on self-reporting
resulted in a lower percentage of incidence (Wee et al., 2020).
In detail, Vaira supported this finding with three different studies
assessing the taste alteration of COVID-19 patients. In the first (Vaira,
Salzano, Fois, Piombino, & De Riu, 2020), the symptom was tested
using self-reporting and the incidence was found to be of 19.4%, in
the others (Vaira, Salzano, Petrocelli, et al., 2020) a test was used and
the incidence was reported to be 73.6 and 51.5%.
With regard to the association between age and reported taste
alteration, clarification is a duty. It is well known how altered taste
perception is related with age and, in details, this association could be
due to a decrease in saliva, drugs assumption, diabetes, malnutrition,
neurological and oral mucosa disorders (Doty, 2018), all affections
often associated with advanced age. This could lead to believe that
the elders did not recognize the symptom during COVID-19 infection.
Furthermore, the resulted correlation between female gender and
taste alteration could be explained by the gender difference in terms
of inflammatory reactions (Lechien et al., 2020), highly expressed
in females or, more simply, by the physiological influence of hormones
in taste perception (Di Fede, Majorana, Manfredi, Pentenero, &
Giuliani, 2014).
Several authors of studies selected reported positive associations
between COVID-19 infection and smell and taste disorders (Bénézit
et al., 2020; Lechien et al., 2020). However, some of them did not dif-
ferentiate between the two symptoms (Beltrán-Corbellini et al., 2020;
Lee, Min, et al., 2020; Roland et al., 2020), therefore data about
taste could be underestimated (Tong et al., 2020). Most authors indi-
cate the presence of these symptoms in absence of rhinitis or nasal
obstruction (Tong et al., 2020; Vaira, Salzano, Petrocelli, et al., 2020),
leading to hypothesize a direct action of the virus in determining this
symptom.
According to some scholars, a possible cause of taste alteration
could be the presence in oral mucosa of ACE2 receptors, identified as
the cellular receptors for SARS CoV-2.
In detail, a work by (Xu et al., 2020) noticed the higher expression
of ACE2 on tongue compared to other sites of oral mucosa. This could
explain the findings reported and gives the reason for the indepen-
dence of this particular symptom from smell alterations. Furthermore,
ACE2 expression in epithelial cell of salivary glands, highlighted by
(Xu, Li, Gan, Du, & Yao, 2020), is even higher than in the lung
cells, indicating that salivary glands might be a potential target for
COVID-19. The glands and their ducts may be further damaged and
therefore a healing process of healing acted by fibroblasts with a
fibrous connective tissue formation may follow. This mechanism,
according to Wang et al. (2020) could be the basis of early manifesta-
tions of COVID-19 such as acute sialadenitis accompanied by pain
and tumor in parotid and submandibular glands. This process could be
followed by chronic sialadenitis due to a decrease in the secretion of
saliva responsible for potential infections and stones in salivary ducts.
These changes in secretion of saliva deserve to be taken into
account during the early diagnosis process, they could be responsible
for taste alteration and oral complication due to hyposcialia (e.g., oral
candidiasis, burning mouth [Campisi et al., 2008]).
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With this in mind, the presence of hyposalivation or other
salivary alterations needs to be carefully evaluated (Vinayachandran &
Balasubramanian, 2020).
Lesions reported in the oral cavity are an important issue to
assess and, where possible, to better frame: concerning them the
knowledge is scarce. At the present, only Martín Carreras-Presas
et al. (2020) described in detail oral lesions during COVID-19 infec-
tion, whereas other findings were reported by dermatological scholars
describing oral manifestations of dermatological diseases (Jimenez-
Cauhe et al., 2020; Rivera-Figueroa et al., 2020; Verdoni et al., 2020).
In addition, in several studies reporting cutaneous changes, informa-
tion about the location of lesions was not provided (Tang et al., 2020).
As reported by Martín Carreras-Presas et al. (2020) and Hedou
et al. (2020), elementary lesions (ulcers or vesciculo-bullous lesions)
can occur as in other viral infections. It is largely demonstrated that
high levels of fatigue and stress could be associated with an increased
risk of reactivation of the HSV (Forbes et al., 2019), a common condi-
tion in cases of flu.
Likewise, Erythema multiforme was largely reported in the litera-
ture in association with viral infections, for example, Adenoviruses,
Enteroviruses, Herpes Viruses, with an occurrence of oral manifesta-
tions in 70% of cases, especially represented by blisters and ulcers
located on lips or non-keratinized mucosa (Scully & Bagan, 2008).
Considering these findings, it is possible that this virus provokes
exanthematous lesions as other viral processes that we are used to
diagnose in the dental practice.
Same considerations are viable for Kawasaki-like disease. Indeed,
one of the most reported risk factors of this disease is viral infection,
such as Adenoviruses, Enteroviruses, Influenza A, Para-influenza type
3; in detail, a study by Chang et al. (2014) highlighted a statistically
significant association between Coronaviridae and KD, demonstrating
also that the 60% of patients positive for Kawasaki had a virus infec-
tion affecting the respiratory tract.
To point out that Erythema Multiforme and KD pathogeneses
could be linked to an inflammatory disorder affecting blood vessels,
therefore we could assume that the oral manifestations of COVID-19
can be traced back to ACE2 endothelial receptors.
A critical point of this narrative review has to be recognized in a
few reported studies from Asian countries (China, Korea and Singa-
pore) about this issue. As some authors yet reported, we have to take
into account that different lifestyles might affect ACE2 expression
(such as diet, cigarette smoking) causing different patterns of clinical
manifestation among different countries with different lifestyles (Li,
Zhou, Yang, & You, 2020).
There are some limitations to this review, due to the design of
the studies included, that were case reports/series, or cross-sectional
or retrospective studies, therefore their scientific contribution could
seem limited. This is an issue considered by authors, however, the cur-
rent socio-economic and medical matters required to deeply investi-
gate and discover as much as possible about this severe infection:
with this in mind, also weak studies were included in the review.
To conclude, we observed that oral signs and symptoms of
COVID-19 are not frequently recognized and reported by patients,
together with the fact that they could be non-specific of this disease.
In this context, differential diagnosis with other chronic conditions is
advisable, always deeply defining a correct and complete anamnesis
of the patient.
However, several diseases present oral involvement as a
first and only manifestation (Capocasale, Perno, Nocini, Albanese, &
Zotti, 2020; Dalessandri et al., 2019; Dioguardi et al., 2016;
Dioguardi et al., 2019; Porter, Mercadante, & Fedele, 2017): this
issue has to be evaluated and therefore assessed also for this new
infection.
In this regard, it could be actually useful that oral professionals
evaluate and categorize all oral involvements of Coronavirus infection:
this important action would allow to not underestimate and mis-
diagnose oral sign and symptom. With these findings in mind, we sug-
gest that all specialists involved in oral health, especially dentists
and dermatologists, could perform the oral examination in patients
suspected or affected by SARS-CoV-2.
Furthermore, it is important to report the presence of any oral
manifestations, especially until little is known. Indeed, the knowledge
of oral signs and symptoms could be important in the dental setting
for performing a more accurate triage of patients and for early diagno-
sis. For example, dental practitioners should include “recent onset of
taste disturbance” or “oral ulcers” as questions of routinely anamnes-
tic questionnaire and filtering out those who are at higher risk from
attending primary healthcare environment.
The oral professionals must be conscious of COVID-19 (Bizzoca,
Campisi, & Muzio, 2020) and their valuable role in controlling out-
breaks. Health care professionals, indeed, could apply up-date triage
before dental procedures and clinically identify early oral signs and
symptoms of COVID-19, they also refer the patients for further inves-
tigation to speed-up self-isolation procedures.
ACKNOWLEDGMENTS
No financial support available for this study.
CONFLICT OF INTEREST
The authors declare no conflict of interest.
AUTHOR CONTRIBUTIONS
Giorgia Capocasale wrote the manuscript; Giorgia Capocasale and
Riccardo Nocini conducted the conceptualization, the methology, the
investigation and the formal analysis; Dario Donadello and Paolo
Faccioni conducted data curation; Francesca Zotti provided review
and editing; Massimo Albanese, Francesca Zotti and Dario Bertossi
provided the validation; Francesca Zotti and Massimo Albanese
reviewed the final manuscript.
DATA AVAILABILITY STATEMENT
Data sharing is not applicable to this article as no new data were cre-
ated or analyzed in this study.
ORCID
Giorgia Capocasale https://orcid.org/0000-0001-8578-8041
6 CAPOCASALE ET AL.
REFERENCES
Beltrán-Corbellini, A., Chico-García, J. L., Martínez-Poles, J., Rodríguez-
Jorge, F., Natera-Villalba, E., Gómez-Corral, J., … Alonso-Cánovas, A.
(2020). Acute-onset smell and taste disorders in the context of
COVID-19: A pilot multicentre polymerase chain reaction based case-
control study. European Journal of Neurology, 27, 1738–1741. https://
doi.org/10.1111/ene.14273
Bénézit, F., Le Turnier, P., Declerck, C., Paillé, C., Revest, M., Dubée, V., …
RAN COVID Study Group. (2020). Utility of hyposmia and hypogeusia
for the diagnosis of COVID-19. The Lancet Infectious Diseases,
S1473-3099(20), 30297–30298.
Bizzoca, M. E., Campisi, G., & Muzio, L. L. (2020). Covid-19 pandemic:
What changes for dentists and oral medicine experts? A narrative
review and novel approaches to infection containment. International
Journal of Environmental Research and Public Health., 17, 3793.
Campisi, G., Panzarella, V., Matranga, D., Calvino, F., Pizzo, G., Lo
Muzio, L., & Porter, S. (2008). Risk factors of oral candidosis: A twofold
approach of study by fuzzy logic and traditional statistic. Archives of
Oral Biology, 53(4), 388–397.
Capocasale, G., Panzarella, V., Tozzo, P., Mauceri, R., Rodolico, V.,
Lauritano, D., & Campisi, G. (2017). Oral verruciform xanthoma and
erythroplakia associated with chronic graft-versus-host disease: A rare
case report and review of the literature. BMC Research Notes,
10(1), 631.
Capocasale, G., Perno, G., Nocini, R., Albanese, M., & Zotti, F. (2020). Role
of telemedicine and smartphone for distant patient management in
dentistry: The new way of triage. Journal of International Society of Pre-
ventive and Community Dentistry, 10(3), 376–378.
Chang, L. Y., Lu, C. Y., Shao, P. L., Lee, P. I., Lin, M. T., Fan, T. Y., …
Huang, L. M. (2014). Viral infections associated with Kawasaki disease.
Journal of the Formosan Medical Association, 113(3), 148–154.
Dalessandri, D., Zotti, F., Laffranchi, L., Migliorati, M., Isola, G.,
Bonetti, S., & Visconti, L. (2019). Treatment of recurrent aphthous sto-
matitis (RAS; aphthae; canker sores) with a barrier forming mouth rinse
or topical gel formulation containing hyaluronic acid: A retrospective
clinical study. BMC Oral Health, 19(1), 153.
Daruich, A., Martin, D., & Bremond-Gignac, D. (2020). Ocular manifesta-
tion as first sign of coronavirus disease 2019 (COVID-19): Interest of
telemedicine during the pandemic context. Journal Français
D'Ophtalmologie, 43(5), 389–391.
Di Fede, O., Majorana, A., Manfredi, M., Pentenero, M., & Giuliani, M.
(2014). Odontoiatria di genere: la condizione femminile nella pratica
odontoiatrica. Dental Cadmos, 82(1), 31–48.
Dioguardi, M., Caloro, G. A., Troiano, G., Giannatempo, G., Laino, L.,
Petruzzi, M., & Lo Muzio, L. (2016). Oral manifestations in chronic ure-
mia patients. Renal Failure, 38(1), 1–6.
Dioguardi, M., Gioia, G. D., Caloro, G. A., Capocasale, G., Zhurakivska, K.,
Troiano, G., … Muzio, L. L. (2019). The association between tooth loss
and Alzheimer's disease: A systematic review with meta-analysis of
case control studies. Dentistry Journal, 7, 49.
Doty, R. L. (2018). Age-related deficits in taste and smell. Otolaryngologic
Clinics of North America, 51(4), 815–825.
Forbes, H., Warne, B., Doelken, L., Brenner, N., Waterboer, T., Luben, R., …
Gkrania-Klotsas, E. (2019). Risk factors for herpes simplex virus type-1
infection and reactivation: Cross-sectional studies among EPIC-
Norfolk participants. PLoS One, 14(5), e0215553.
Gelardi, M., Trecca, E., Cassano, M., & Ciprandi, G. (2020). Smell and taste
dysfunction during the COVID-19 outbreak: A preliminary report. Acta
Bio-Medica: Atenei Parmensis, 91(2), 230–231.
Giacomelli, A., Pezzati, L., Conti, F., Bernacchia, D., Siano, M., Oreni, L., …
Galli, M. (2020). Self-reported olfactory and taste disorders in SARS-
CoV-2 patients: A cross-sectional study. Clinical Infectious Diseases, 71,
889–890.
Hedou, M., Carsuzaa, F., Chary, E., Hainaut, E., Cazenave-Roblot, F., &
Masson Regnault, M. (2020). Comment on “cutaneous manifestations
in COVID-19: A first perspective” by Recalcati S. Journal of the
European Academy of Dermatology and Venereology, 34, e299–e300.
https://doi.org/10.1111/jdv.16519
Hellewell, J., Abbott, S., Gimma, A., Bosse, N. I., Jarvis, C. I., Russell, T. W.,
… Eggo, R. M. (2020). Feasibility of controlling COVID-19 outbreaks
by isolation of cases and contacts. Lancet Global Health, 8(4),
e488–e496.
Hjelmesæth, J., & Skaare, D. (2020). Loss of smell or taste as the only
symptom of COVID-19. Journal of the Norwegian Medical Association,
140(7).
Jang, Y., Son, H. J., Lee, S., Lee, E. J., Kim, T. H., & Park, S. Y. (2020). Olfac-
tory and taste disorder: The first and only sign in a patient with SARS-
CoV-2 pneumonia. Infection Control and Hospital Epidemiology, 41,
1103.
Jiang, F., Deng, L., Zhang, L., Cai, Y., Cheung, C. W., & Xia, Z. (2020).
Review of the clinical characteristics of coronavirus disease 2019
(COVID-19). Journal of General Internal Medicine, 35(5), 1545–1549.
Jimenez-Cauhe, J., Ortega-Quijano, D., Carretero-Barrio, I., Suarez-
Valle, A., Saceda-Corralo, D., Moreno-Garcia Del Real, C., &
Fernandez-Nieto, D. (2020). Erythema multiforme-like eruption in
patients with COVID-19 infection: Clinical and histological findings.
Clinical and Experimental Dermatology, 45, 892–895. https://doi.org/
10.1111/ced.14281
Lechien, J. R., Chiesa-Estomba, C. M., De Siati, D. R., Horoi, M., Le
Bon, S. D., Rodriguez, A., … Saussez, S. (2020). Olfactory and gustatory
dysfunctions as a clinical presentation of mild-to-moderate forms of
the coronavirus disease (COVID-19): A multicenter European study.
European Archives of Oto-Rhino-Laryngology, 6, 1–11.
Lee, I. C., Huo, T. I., & Huang, Y. H. (2020). Gastrointestinal and liver
manifestations in patients with COVID-19. Journal of the Chinese
Medical Association, 83, 521–523. https://doi.org/10.1097/JCMA.
0000000000000319
Lee, Y., Min, P., Lee, S., & Kim, S. W. (2020). Prevalence and duration of
acute loss of smell or taste in COVID-19 patients. Journal of Korean
Medical Science, 35(18), e174.
Li, Y., Zhou, W., Yang, L., & You, R. (2020). Physiological and pathological
regulation of ACE2, the SARS-CoV-2 receptor. Pharmacological
Research, 157, 104833.
Mao, L., Jin, H., Wang, M., Hu, Y., Chen, S., He, Q., … Hu, B. (2020). Neuro-
logic manifestations of hospitalized patients with coronavirus disease
2019 in Wuhan, China. JAMA Neurology, 77, 683–690.
Martín Carreras-Presas, C., Amaro Sánchez, J., López-Sánchez, A. F., Jané-
Salas, E., & Somacarrera Pérez, M. L. (2020). Oral vesiculobullous
lesions associated with SARS-CoV-2 infection. Oral Diseases. https://
doi.org/10.1111/odi.13382
Melley, L. E., Bress, E., & Polan, E. (2020). Hypogeusia as the initial pre-
senting symptom of COVID-19. BMJ Case Report, 13(5), e236080.
Paderno, A., Schreiber, A., Grammatica, A., Raffetti, E., Tomasoni, M.,
Gualtieri, T., … Mattavelli, D. (2020). Smell and taste alterations in
Covid-19: A cross-sectional analysis of different cohorts. International
Forum of Allergy & Rhinology, 10(8), 955–962. https://doi.org/10.
1002/alr.22610
Porter, S. R., Mercadante, V., & Fedele, S. (2017). Oral manifestations of
systemic disease. British Dental Journal, 223(9), 683–691.
Rivera-Figueroa, E. I., Santos, R., Simpson, S., & Garg, P. (2020). Incomplete
Kawasaki disease in a child with Covid-19. Indian Pediatrics, 57,
680–681.
Roland, L. T., Gurrola, J. G., Loftus, P. A., Cheung, S. W., & Chang, J. L.
(2020). Smell and taste symptom-based predictive model for COVID-
19 diagnosis. International Forum of Allergy & Rhinology, 10, 832–838.
https://doi.org/10.1002/alr.22602
Scully, C., & Bagan, J. (2008). Oral mucosal diseases: Erythema multiforme.
British Journal of Oral and Maxillofacial Surgery, 46(2), 90–95.
Sohrabi, C., Alsafi, Z., O'Neill, N., Khan, M., Kerwan, A., Al-Jabir, A., …
Agha, R. (2020). World Health Organization declares global
CAPOCASALE ET AL. 7
emergency: A review of the 2019 novel coronavirus (COVID-19).
International Journal of Surgery, 76, 71–76.
Tang, K., Wang, Y., Zhang, H., Zheng, Q., Fang, R., & Sun, Q. (2020). Cuta-
neous manifestations of the coronavirus disease 2019 (COVID-19): A
brief review. Dermatologic Therapy, e13528.
Tong, J. Y., Wong, A., Zhu, D., Fastenberg, J. H., & Tham, T. (2020). The
prevalence of olfactory and gustatory dysfunction in COVID-19
patients: A systematic review and meta-analysis. Otolaryngology-Head
and Neck Surgery, 163, 3–11.
Vaira, L. A., Deiana, G., Fois, A. G., Pirina, P., Madeddu, G., De Vito, A., …
De Riu, G. (2020). Objective evaluation of anosmia and ageusia in
COVID-19 patients: Single-center experience on 72 cases. Head &
Neck, 42, 1252–1258. https://doi.org/10.1002/hed.26204
Vaira, L. A., Salzano, G., Deiana, G., & De Riu, G. (2020). Anosmia and
ageusia: Common findings in COVID-19 patients. The Laryngoscope,
130(7), 1787.
Vaira, L. A., Salzano, G., Fois, A. G., Piombino, P., & De Riu, G. (2020).
Potential pathogenesis of ageusia and anosmia in COVID-19 patients.
International Forum of Allergy & Rhinology, 10, 1103–1104. https://doi.
org/10.1002/alr.22593
Vaira, L. A., Salzano, G., Petrocelli, M., Deiana, G., Salzano, F. A., & De
Riu, G. (2020). Validation of a self-administered olfactory and gusta-
tory test for the remotely evaluation of COVID-19 patients in home
quarantine. Head & Neck, 42, 1570–1576. https://doi.org/10.1002/
hed.26228
Verdoni, L., Mazza, A., Gervasoni, A., Martelli, L., Ruggeri, M.,
Ciuffreda, M., … D'Antiga, L. (2020). An outbreak of severe Kawasaki-
like disease at the Italian epicentre of the SARS-CoV-2 epidemic: An
observational cohort study. Lancet, 395, 1771–1778. https://doi.org/
10.1016/S0140-6736(20)31103-X
Villalba, N. L., Maouche, Y., Ortiz, M. B. A., Sosa, Z. C., Chahbazian, J. B.,
Syrovatkova, A., … Zulfiqar, A. A. (2020). Anosmia and dysgeusia in the
absence of other respiratory diseases: Should COVID-19 infection be
considered? European Journal of Case Reports in Internal Medicine, 7(4),
001641.
Vinayachandran, D., & Balasubramanian, S. (2020). Is gustatory impairment
the first report of an oral manifestation in COVID-19? Oral Diseases.
https://doi.org/10.1111/odi.13371
Wan, Y., Shang, J., Graham, R., Baric, R. S., & Li, F. (2020). Receptor recog-
nition by the novel coronavirus from Wuhan: An analysis based on
decade-long structural studies of SARS coronavirus. Journal of Virology,
94(7), e00127-20.
Wang, J., Wang, D., Chen, G. C., Tao, X. W., & Zeng, L. K. (2020). SARS-
CoV-2 infection with gastrointestinal symptoms as the first manifesta-
tion in a neonate. Zhongguo Dang Dai Er Ke Za Zhi, 22(3), 211–214.
Wang, C., Wu, H., Ding, X., Ji, H., Jiao, P., Song, H., … Du, H. (2020). Does
infection of 2019 novel coronavirus cause acute and/or chronic
sialadenitis? Medical Hypotheses, 140, 109789.
Wee, L. E., Chan, Y. F. Z., Teo, N. W. Y., Cherng, B. P. Z., Thien, S. Y.,
Wong, H. M., … Tan, T. T. (2020). The role of self-reported olfactory
and gustatory dysfunction as a screening criterion for suspected
COVID-19. European Archives of Oto-Rhino-Laryngology, 24, 1–2.
Xu, J., Li, Y., Gan, F., Du, Y., & Yao, Y. (2020). Salivary glands: Potential res-
ervoirs for COVID-19 asymptomatic infection. Journal of Dental
Research, 99, 989.
Xu, H., Zhong, L., Deng, J., Peng, J., Dan, H., Zeng, X., … Chen, Q. (2020).
High expression of ACE2 receptor of 2019-nCoV on the epithelial
cells of oral mucosa. International Journal of Oral Science, 12(1), 8.
Yan, C. H., Faraji, F., Prajapati, D. P., Ostrander, B. T., & DeConde, A. S.
(2020). Self-reported olfactory loss associates with outpatient clinical
course in Covid-19. International Forum of Allergy & Rhinology, 10,
821–831. https://doi.org/10.1002/alr.22592
Zhang, H., Penninger, J. M., Li, Y., Zhong, N., & Slutsky, A. S. (2020). Angio-
tensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: Molec-
ular mechanisms and potential therapeutic target. Intensive Care
Medicine, 46(4), 586–590.
Zotti, F., Nocini, R., Capocasale, G., Fior, A., Peretti, M., & Albanese, M.
(2020). Malignant transformation evidences of Oral Lichen Planus:
When the time is of the essence. Oral Oncology, 104, 104594.
How to cite this article: Capocasale G, Nocini R, Faccioni P,
et al. How to deal with coronavirus disease 2019: A
comprehensive narrative review about oral involvement of the
disease. Clin Exp Dent Res. 2020;1–8. https://doi.org/10.
1002/cre2.332
8 CAPOCASALE ET AL.
